NVCR logo

NVCRNovoCure Ltd

$17.56
$0.07
(0.40%)
Today
Closed $17.78
$0.2199
(1.24%)
After Hours
Updated: 06:08 PM EDT
EarningsJul 23
Mkt Cap$2.06B
Vol1.04M
News
all
press releases
Strength Seen in Nurix Therapeutics (NRIX): Can Its 6.8% Jump Turn into More Strength?
Nurix Therapeutics (NRIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
News Placeholder
More News
News Placeholder
3 Overlooked Stocks Set to Soar in 2026
Key PointsAxsome Therapeutics and NovoCure Limited recently received FDA approvals for their therapies...
Nasdaq News: Markets
News Placeholder
NovoCure (NASDAQ:NVCR) Price Target Raised to $17.00 at Wells Fargo & Company
Wells Fargo & Company lifted their price target on shares of NovoCure from $13.50 to $17.00 and gave the stock an 'equal weight' rating in a research note on Monday...
MarketBeat
News Placeholder
International Markets and NovoCure (NVCR): A Deep Dive for Investors
Review NovoCure's (NVCR) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Zacks
News Placeholder
NovoCure (NASDAQ:NVCR) Trading 6.8% Higher - Should You Buy?
NovoCure (NASDAQ:NVCR) Stock Price Up 6.8% - Here's Why...
MarketBeat
News Placeholder
NovoCure (NASDAQ:NVCR) Announces Earnings Results
NovoCure (NASDAQ:NVCR - Get Free Report) released its quarterly earnings results on Thursday. The medical equipment provider reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of ($0.49) by ($0.13). The business had revenue of $174.06 million for the quarter...
MarketBeat
News Placeholder
NovoCure (NVCR) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
News Placeholder
NovoCure (NASDAQ:NVCR) Shares Gap Up - Should You Buy?
NovoCure (NASDAQ:NVCR) Shares Gap Up - Time to Buy...
MarketBeat
News Placeholder
Caterpillar Posts Upbeat Q1 Results, Joins Garrett Motion, Wesco International, TTM Technologies And Other Big Stocks Moving Higher On Thursday
US stocks mixed, Dow up 400 pts. Caterpillar, Bandwidth, Everspin, Vistance, IMPINJ, Novocure, Viavi, Garrett, Hertz, Ranpak all gain in Q1.read more...
Benzinga
News Placeholder
NovoCure Q1 Earnings Call Highlights
NovoCure (NASDAQ:NVCR) reported first-quarter 2026 results highlighted by double-digit year-over-year growth in both active patients and net revenue, driven in part by strength outside the U.S. and an early commercial ramp for its newly approved pancreatic cancer therapy. Executive Chairman Bill Doy...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.